Drug Database
Back to search

France· FR:61648894

LEVOBUPIVACAINE ALTAN 5 mg/mL, solution injectable/pour perfusion

A levobupivacaine product containing chlorhydrate de lévobupivacaïne, registered in France by ALTAN PHARMACEUTICALS (ESPAGNE). The same ATC class is registered in 10 of our 19 countries.

ATC N01BB10

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLEVOBUPIVACAINE ALTAN 5 mg/mL, soluti…ATCN01BB10REGISTER NO.FR:61648894PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de lévobupivacaïneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levobupivacaine is registered in 10 of 19 countries.

Countries holding a registration under ATC N01BB10 (levobupivacaine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose
Search levobupivacaine products by name

Levobupivacaine · ATC N01BB10

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE LÉVOBUPIVACAÏNE
Manufacturer
ALTAN PHARMACEUTICALS (ESPAGNE)
Country
France (FR)
ATC code
N01BB10
ATC class
Levobupivacaine
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955060338
    10 ampoule(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

101 interactions on record for levobupivacaine.

Graded by severity as the source publishes them — 73 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levobupivacaine against other medicinesHow interaction checks work

Levobupivacaine · interactions on record

101 records

  • 73 moderate
  • 28 minor

Most severe, free to view

  • ClotrimazoleA01AB18moderate
  • LidocainA01AE01moderate
  • CimetidineA02BA01moderate
  • AprepitantA04AD12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levobupivacaine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levobupivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Levobupivacaine Fresenius Kabi
  • Czechia · Levobupivacaine Kabi
  • Spain · Levobupivacaína Altan, Levobupivacaína Kabi
  • United Kingdom (Northern Ireland) · Levobupivacaine, Levobupivacaine Altan
  • Croatia · Levobupivakain Kabi
  • Ireland · Levobupivacaine
  • Italy · Levobupivacaina Altan, Levobupivacaina Bioindustria L.I.M
  • Netherlands · Levobupivacaïne Fresenius Kabi, Levobupivacaïne Molteni
  • Poland · Levobupivacaine Molteni
  • Portugal · Levobupivacaína Altan, Levobupivacaína Kabi
  • Sweden · Levobupivacaine Molteni
  • Slovenia · Levobupivakain Kabi
  • Slovakia · Levobupivacaine Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8078ea6-a91c-43c5-b2df-721427da596e
GET /v1/drugs/f8078ea6-a91c-43c5-b2df-721427da596e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61648894",
  "date_amm": "2018-10-24",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE LÉVOBUPIVACAÏNE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable ou pour perfusion",
  "voies_administration": "infiltration;intrathécale;péribulbaire;péridurale;périneurale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about levobupivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console